Mimedx Group, Inc.
A maker of regenerative medicine products that turn donated human placental and amniotic tissue into natural healing dressings used by doctors to treat chronic wounds and support surgical recovery. Its best-known brands include EPIFIX, EPICORD, and AMNIOFIX. The name blends "medical" and "Medx," and it was adopted in 2008 when a dormant Utah shell company merged with a Florida biomaterials startup to form the company now based in Marietta, Georgia. Amniotic tissue has actually been used to dress wounds for over a century—surgeons once even sewed "afterbirth" into patients before modern safety standards.
Sold 1.99M
Granted 5.21M · Bought 3.16M · Sold 150.0K
Granted 38.1K
Granted 766.0K · Bought 82.2K · Sold 50.5K
Granted 10.5K · Sold 546.1K
Granted 2.19M · Sold 320.6K
Granted 144.7K
Granted 10.60M · Bought 127.2K · Sold 1.92M
Granted 16.0K · Bought 16.7K
Granted 594.4K · Bought 300.0K
Granted 91.8K · Bought 67.2K
Granted 1.51M · Bought 41.7K · Sold 944.5K
Granted 770.1K · Sold 82.4K
Granted 928.4K · Sold 224.6K
Granted 518.8K · Bought 5.0K
Granted 435.1K
Granted 641.4K · Sold 123.2K
Granted 451.2K · Sold 21.1K
Granted 309.3K
Granted 94.2K
Granted 504.7K · Sold 186.9K
Granted 288.5K · Sold 66.3K
Granted 304.4K
Granted 263.7K
Granted 254.9K
Granted 211.4K · Sold 15.2K
Granted 212.8K
Granted 230.7K · Bought 62.5K · Sold 100.0K
Granted 212.1K · Sold 22.5K
Granted 181.9K
Granted 153.4K · Bought 28.2K
Granted 167.8K · Bought 4.2K
Granted 140.1K · Bought 16.7K
Granted 105.0K · Bought 58.3K · Sold 6.0K
Granted 111.0K · Sold 11.7K
Granted 130.1K
Granted 111.4K · Bought 5.0K
Granted 111.4K · Bought 10.0K
Granted 117.0K
Granted 108.5K
Granted 108.5K
Granted 203.3K
Bought 42.0K
Granted 25.3K
Sold 20.00M
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Okumus Ahmet H +2 co-filers10% owner · 6 transactions | — | 58.18Mas of Jan 2019 | — | — | 1.99M |
| Falcon Fund 2 Holding Company, L.P.10% owner · 1 transaction | — | 28.20Mas of Dec 2023 | — | — | — |
| Petit Parker HChairman & CEO, Director · 85 transactions | — | 4.65Mas of Feb 2018 | 5.21M | 3.16M | 150.0K |
| Barry RichardDirector · 1 transaction | — | 3.34Mas of Aug 2020 | 38.1K | — | — |
| Koob Charles EDirector · 34 transactions | — | 2.92Mas of Oct 2020 | 766.0K | 82.2K | 50.5K |
| Miller Matthew JergesenEVP · 11 transactions | — | 2.69Mas of Dec 2009 | 10.5K | — | 546.1K |
| Wright Timothy RChief Executive Officer, Director · 10 transactions | — | 1.71Mas of Jun 2022 | 2.19M | — | 320.6K |
| Hack BruceDirector · 11 transactions | — | 1.49Mas of Jun 2019 | 144.7K | — | — |
| Gorlin SteveDirector · 59 transactions | — | 1.35Mas of May 2013 | 10.60M | 127.2K | 1.92M |
| Rooke Andrew K. Jr.Director · 2 transactions | — | 1.12Mas of Oct 2009 | 16.0K | 16.7K | — |
| Capper Joseph HChief Executive Officer · 5 transactions | — | 904.7K | 594.4K | 300.0K | — |
| Eichler Kurt MDirector · 6 transactions | — | 663.4Kas of Jul 2012 | 91.8K | 67.2K | — |
| Taylor William CharlesPresident and COO, Director · 61 transactions | — | 659.3Kas of Feb 2018 | 1.51M | 41.7K | 944.5K |
| Carlson Peter MChief Financial Officer · 18 transactions | — | 656.4Kas of May 2023 | 770.1K | — | 82.4K |
| Hulse William Frank IVGeneral Counsel and CAO · 30 transactions | — | 543.2K | 928.4K | — | 224.6K |
| Doug RiceChief Financial Officer · 9 transactions | — | 508.7K | 518.8K | 5.0K | — |
| Newton ToddDirector · 8 transactions | +12.3% | 463.7K | 435.1K | — | — |
| Whitlow Ricci SChief Operating Officer · 10 transactions | — | 462.8K | 641.4K | — | 123.2K |
| Kashyap RohitPresident, WC & Surgical · 5 transactions | — | 430.1Kas of Aug 2022 | 451.2K | — | 21.1K |
| Landy MarkEVP & Chief Strategy Officer · 8 transactions | — | 379.9Kas of Jul 2019 | 309.3K | — | — |
| Koob Thomas JChief Scientific Officer · 1 transaction | — | 344.2Kas of Oct 2008 | 94.2K | — | — |
| Stein Robert BenjaminPresident, Regenerative Med. · 18 transactions | — | 317.8Kas of May 2023 | 504.7K | — | 186.9K |
| Maersk-Moller KimberlyChief Commercial Officer · 13 transactions | — | 309.6K | 288.5K | — | 66.3K |
| Senken Michael J.Chief Financial Officer · 17 transactions | — | 273.5Kas of Feb 2018 | 304.4K | — | — |
| Bierman James LDirector · 8 transactions | — | 263.7K | 263.7K | — | — |
| Hawkins William ADirector · 9 transactions | — | 254.9K | 254.9K | — | — |
| Turner Scott MSVP, Operations & Procurement · 19 transactions | — | 226.6Kas of May 2022 | 211.4K | — | 15.2K |
| Behrens M KathleenDirector · 7 transactions | — | 212.8Kas of Jun 2025 | 212.8K | — | — |
| McCaw Roberta LGeneral Counsel and Secretary · 5 transactions | — | 193.2Kas of Feb 2015 | 230.7K | 62.5K | 100.0K |
| Phelan William LawrenceChief Accounting Officer · 14 transactions | — | 184.2Kas of May 2023 | 212.1K | — | 22.5K |
| Laurencin Cato TDirector · 7 transactions | — | 181.9Kas of Jun 2025 | 181.9K | — | — |
| Bleser Joseph GDirector · 11 transactions | — | 181.5Kas of Jun 2019 | 153.4K | 28.2K | — |
| Haden Alexandra OGeneral Counsel & Secretary · 20 transactions | — | 158.2Kas of Feb 2019 | 167.8K | 4.2K | — |
| Dewberry J TerryDirector · 8 transactions | — | 156.8Kas of Aug 2020 | 140.1K | 16.7K | — |
| Papasan Larry WDirector · 19 transactions | — | 140.2Kas of Feb 2019 | 105.0K | 58.3K | 6.0K |
| Graves MarkSVP & Chief Compliance Officer · 10 transactions | — | 133.6Kas of May 2022 | 111.0K | — | 11.7K |
| Giuliani Michael JDirector · 5 transactions | — | 130.1Kas of Jun 2023 | 130.1K | — | — |
| Yeston NeilDirector · 8 transactions | — | 126.4Kas of Oct 2020 | 111.4K | 5.0K | — |
| Evans Charles RobertDirector · 7 transactions | — | 121.4Kas of Oct 2020 | 111.4K | 10.0K | — |
| Gardner PhyllisDirector · 5 transactions | — | 117.0Kas of Jun 2023 | 117.0K | — | — |
| Olson TiffanyDirector · 3 transactions | — | 108.5K | 108.5K | — | — |
| Puhy Dorothy EDirector · 3 transactions | — | 108.5K | 108.5K | — | — |
| Borkowski EdwardEVP & Interim CFO · 3 transactions | — | 87.9Kas of Feb 2019 | 203.3K | — | — |
| Culumber Michael J.Chief Financial Officer · 2 transactions | — | 52.5Kas of Dec 2009 | — | 42.0K | — |
| Aguilar Luis ADirector · 2 transactions | — | 25.3Kas of Feb 2019 | 25.3K | — | — |
| Edwards Ken Cleonformer Dir, Pres. & Treas. · 1 transaction | — | 0as of Feb 2008 | — | — | 20.00M |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -22.76M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.